Prognostic evaluation of early detection of relapse in adult acute leukemia.

Abstract

A criterion was established in a previous study to detect the relapse of adult acute leukemia in its early stage, i.e., when lymphocytes in peripheral blood increased over 45% of the leukocytes during the maintenance therapy, bone marrow puncture was immediately performed to examine the leukemic cells. By this criterion the relapse was detected earlier than by other criteria. To study the effect of early detection of the relapse in adult acute leukemia on the results, the second remission rate and the survival time were compared between the following groups. Group I consisted of 11 patients, whose relapse was determined by our criterion. Group II consisted of 8 patients whose relapse was determined by the appearance of leukemic cells in peripheral blood. The second remission was accomplished in 7 of 11 patients in Group 1(64%) and in 1 of 8 in Group 11 (13%) (p <0.05). The mean (+s.D.) duration of complete remission in Group I was 9.7+ 7.8 months and not significantly longer than the value in Group 11(5.3 +3.9 months). The interval from relapse to death was 10.3±5.9 and 6.1±3.8 months in Groups I and II, respectively. The interval from relapse to death of 7 patients who accomplished the second remission in Group I was 12.5+5.5 months. This interval was significantly longer than in Group II (p <0.02). The mean survival time was 22.2± 9.6 months in Group I and 13+ 2.5 months in Group II. The mean survival time of 7 patients accomplished the second remission in Group I was 26. 7±9.4 months which was significantly longer than in Group II (p <0.01). The results showed that our criterion to detect relapse in the early stage was effective for prolongation of the survival time in adult acute leukemia. early detection of relapse ; adult acute leukemia ; percentage of lymphocyte ; survival time ; second remission rateThe complete remission rate in adult acute leukemia in Japan has recently been over 80% owing to the development of antileukemic agents and improved combination chemotherapy. Next important problems in control of acute leukemia in adults would be the duration of maintenance therapy, the time of second